Related references
Note: Only part of the references are listed.Early Prediction by 18F-FDG PET/CT for Progression-Free Survival and Overall Survival in Patients With Metastatic Colorectal Cancer Receiving Third-Line Cetuximab-Based Therapy
Feng-Yuan Liu et al.
CLINICAL NUCLEAR MEDICINE (2015)
The Prognostic Significance of Metabolic Response Heterogeneity in Metastatic Colorectal Cancer
Alain Hendlisz et al.
PLOS ONE (2015)
Regorafenib assessment in refractory advanced colorectal cancer: RegARd-C study protocol
Alain Hendlisz et al.
BMJ OPEN (2015)
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
Ronald Boellaard et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Molecular Aspects of Resistance to Biological and Non-Biological Drugs and Strategies to Overcome Resistance in Colorectal Cancer
T. Troiani et al.
CURRENT MEDICINAL CHEMISTRY (2014)
Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
Sally F. Barrington et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
Bruce D. Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Positron Emission Tomography/Computed Tomography and Biomarkers for Early Treatment Response Evaluation in Metastatic Colon Cancer
Bodil E. Engelmann et al.
ONCOLOGIST (2014)
CT versus FDG-PET/CT response evaluation in patients with metastatic colorectal cancer treated with irinotecan and cetuximab
Kristin Skougaard et al.
CANCER MEDICINE (2014)
Comparison of PET metabolic indices for the early assessment of tumour response in metastatic colorectal cancer patients treated by polychemotherapy
Jacques-Antoine Maisonobe et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
Axel Grothey et al.
LANCET (2013)
Serial FDG-PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapy
A. Hendlisz et al.
ANNALS OF ONCOLOGY (2012)
Regorafenib (BAY 73-4506) in advanced colorectal cancer: a phase I study
D. Strumberg et al.
BRITISH JOURNAL OF CANCER (2012)
A Phase I Dose-Escalation Study of Regorafenib (BAY 73-4506), an Inhibitor of Oncogenic, Angiogenic, and Stromal Kinases, in Patients with Advanced Solid Tumors
Klaus Mross et al.
CLINICAL CANCER RESEARCH (2012)
Lesion-based detection of early chemosensitivity using serial static FDG PET/CT in metastatic colorectal cancer
Irene Buvat et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
FDG-PET: for early prediction of response to the first-line chemotherapy in metastatic colorectal cancer?
C. Arslan et al.
ANNALS OF ONCOLOGY (2009)
Early prediction of response to first-line chemotherapy by sequential [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with advanced colorectal cancer
P. Bystrom et al.
ANNALS OF ONCOLOGY (2009)
Beyond RECIST: Molecular and functional imaging techniques for evaluation of response to targeted therapy
I. M. E. Desar et al.
CANCER TREATMENT REVIEWS (2009)
Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
Jedd D. Wolchok et al.
CLINICAL CANCER RESEARCH (2009)
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
Richard L. Wahl et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Chemotherapy response evaluation with FDG-PET in patients with colorectal cancer
L. F. de Geus-Oei et al.
ANNALS OF ONCOLOGY (2008)
The lessons of GIST - PET and PET/CT: A new paradigm for imaging
Annick D. Van den Abbeele
ONCOLOGIST (2008)
A small animal positron emission tomography study of the effect of chemotherapy and hormonal therapy on the uptake of 2-deoxy-2-[F-18]fluoro-D-glucose in murine models of breast cancer
Antonio Aliaga et al.
MOLECULAR IMAGING AND BIOLOGY (2007)
Flare response in F-18-fluoride ion PET bone scanning
AA Wade et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2006)
18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec®)
S Stroobants et al.
EUROPEAN JOURNAL OF CANCER (2003)
Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum
MH Whiteford et al.
DISEASES OF THE COLON & RECTUM (2000)
Share Paper
